Daul A - Search Results

1

Continuous venovenous hemodialysis treatment in critically ill patients after liver transplantation.

Lütkes P, Lutz J, Loock J, Daul A, Broelsch C, Philipp T, Heemann U. Lütkes P, et al. Among authors: daul a. Kidney Int Suppl. 1999 Nov;(72):S71-4. Kidney Int Suppl. 1999. PMID: 10560810 Free article.

2

A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD).

Mitchell A, Daul AE, Beiderlinden M, Schäfers RF, Heemann U, Kribben A, Peters J, Philipp T, Wenzel RR. Mitchell A, et al. Among authors: daul ae. Clin Nephrol. 2003 Feb;59(2):106-14. doi: 10.5414/cnp59106. Clin Nephrol. 2003. PMID: 12608553

3

Exercise during hemodialysis.

Daul AE, Schäfers RF, Daul K, Philipp T. Daul AE, et al. Among authors: daul k. Clin Nephrol. 2004 May;61 Suppl 1:S26-30. Clin Nephrol. 2004. PMID: 15233244 Review.

4

[A patient with severe hyperkalaemia -- an emergency after RALES].

Nürnberger J, Daul A, Philipp T. Nürnberger J, et al. Among authors: daul a. Dtsch Med Wochenschr. 2005 Sep 9;130(36):2008-11. doi: 10.1055/s-2005-872620. Dtsch Med Wochenschr. 2005. PMID: 16143930 German.

5

[Acute hemolysis with subsequent life-threatening pancreatitis in hemodialysis. A complication which is not preventable with current dialysis equipment].

Daul AE, Schäfers RF, Wenzel RR, Loew H, Windeck R, Philipp T. Daul AE, et al. Dtsch Med Wochenschr. 1994 Sep 23;119(38):1263-9. doi: 10.1055/s-2008-1058831. Dtsch Med Wochenschr. 1994. PMID: 7924917 German.

6

[Commercial kidney transplantation in the "third world." Risks, ethical-moralistic questions and urgently required consequences].

Daul AE, Metz-Kurschel U, Philipp T. Daul AE, et al. Dtsch Med Wochenschr. 1996 Oct 25;121(43):1341-4. doi: 10.1055/s-2008-1043150. Dtsch Med Wochenschr. 1996. PMID: 8964216 Review. German. No abstract available.

7

Antihypertensive drugs and the sympathetic nervous system.

Wenzel RR, Bruck H, Noll G, Schäfers RF, Daul AE, Philipp T. Wenzel RR, et al. Among authors: daul ae. J Cardiovasc Pharmacol. 2000;35(7 Suppl 4):S43-52. doi: 10.1097/00005344-200000004-00006. J Cardiovasc Pharmacol. 2000. PMID: 11346218 Review.

8

Disodium cromoglycate does not prevent terbutaline-induced desensitization of beta 2-adrenoceptor-mediated cardiovascular in vivo functions in human volunteers.

Schäfers RF, Piest U, von Birgelen C, Jakubetz J, Daul AE, Philipp T, Brodde OE. Schäfers RF, et al. Among authors: daul ae. J Cardiovasc Pharmacol. 1999 May;33(5):822-7. doi: 10.1097/00005344-199905000-00021. J Cardiovasc Pharmacol. 1999. PMID: 10226872 Clinical Trial.

9

Ketotifen and cardiovascular effects of xamoterol following single and chronic dosing in healthy volunteers.

Schäfers RF, Karl I, Mennicke K, Daul AE, Philipp T, Brodde OE. Schäfers RF, et al. Among authors: daul ae. Br J Clin Pharmacol. 1999 Jan;47(1):59-66. doi: 10.1046/j.1365-2125.1999.00854.x. Br J Clin Pharmacol. 1999. PMID: 10073741 Free PMC article. Clinical Trial.

10

Enhanced G protein activation in IDDM patients with diabetic nephropathy.

Pietruck F, Spleiter S, Daul A, Philipp T, Derwahl M, Schatz H, Siffert W. Pietruck F, et al. Among authors: daul a. Diabetologia. 1998 Jan;41(1):94-100. doi: 10.1007/s001250050872. Diabetologia. 1998. PMID: 9498636

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters